Skip to content
ChickenStockChickenStock
ResearchWVE
Wave Life Sciences logo

Wave Life Sciences (WVE) stock

NASDAQ

$3.13-0.79%(-0.02)

As of the Nov 13, 2026 close (U.S. Eastern)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

-2.94x

Net loss — not comparable

P/B

1.53x

P/S

9.49x

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue in the latest quarter: $13M.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Oct 27, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

13 SEC filings
  • Tan Aik NaDirector · Oct 5, 2026Grant or award10,700 shares · $0
    Avg. price $035,668 shares held after
  • RA CAPITAL MANAGEMENT, L.P.Director · Oct 5, 2026Grant or award10,700 shares · $0
    Avg. price $039,515 shares held after
  • TAKANASHI KENDirector · Oct 5, 2026Grant or award10,700 shares · $0
    Avg. price $030,779 shares held after
  • Wagner Heidi LDirector · Oct 5, 2026Grant or award10,700 shares · $0
    Avg. price $055,630 shares held after
  • Rawcliffe AdrianDirector · Oct 5, 2026Grant or award10,700 shares · $0
    Avg. price $010,700 shares held after
  • Verdine Gregory L.Director · Oct 5, 2026Grant or award10,700 shares · $0
    Avg. price $0200,917 shares held after
  • CORRIGAN MARKDirector · Oct 5, 2026Grant or award10,700 shares · $0
    Avg. price $039,515 shares held after
  • HENRY CHRISTIAN ODirector · Oct 5, 2026Grant or award10,700 shares · $0
    Avg. price $023,400 shares held after
  • Rawcliffe AdrianDirector · Aug 12, 2026Open-market sale12,700 shares · $67K
    Avg. price $5.290 shares held after
  • Wagner Heidi LDirector · Aug 11, 2026Open-market sale7,000 shares · $42K
    Avg. price $6.0144,930 shares held after
  • TAKANASHI KENDirector · Aug 11, 2026Open-market sale3,864 shares · $23K
    Avg. price $6.0120,079 shares held after
  • Tan Aik NaDirector · Aug 11, 2026Open-market sale432 shares · $3K
    Avg. price $6.0124,968 shares held after
  • Wagner Heidi LDirector · Aug 11, 2026Option exercise7,000 shares · $42K
    Avg. price $5.9751,930 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Wave Life Sciences (WVE) stock information

NASDAQ

Wave Life Sciences (WVE) is listed on NASDAQ. Its market capitalization is about $617M. On trailing-twelve-month earnings the P/E ratio is -2.94, and the P/B ratio is 1.53. Return on equity is -52.2%. These figures are computed in-house from official filings and are reference information only.

Wave Life Sciences — frequently asked questions

What is the P/E ratio of Wave Life Sciences (WVE)?
On a trailing-twelve-month basis, WVE trades at a P/E ratio of -2.94. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Wave Life Sciences?
WVE has a market capitalization of about $617M. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.